Quantum BioPharma Ltd. (QNTM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $9.26M
Last updated: Nov 17, 2026 at 4:31 PM ET
Quantum BioPharma Ltd. (QNTM) Stock Chart
Quantum BioPharma (QNTM) has a latest price of $1.59 on Nov 17, 2026, 87.2% below its 52-week high of $12.42. Its price fell 78.4% over the past 12 months. The month-end price fell 99.9% since Jun 2018, a compound annual decline of 54.5%.
Price Chart
From Jun 2018 to Oct 2026, its highest month-end close was $7,207.79 in Sep 2018 and its lowest $2.38 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart QNTM with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for QNTM.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 54.8%, and over 6 months it fell 77.3%. The month-end price fell 96.5% over the 3 years through Oct 2026, a compound annual decline of 67.2%.
| Period | Change |
|---|---|
| 1 month | -34.0% |
| 3 months | -54.8% |
| 6 months | -77.3% |
| 12 months | -78.4% |
| 12 months, with dividends | -78.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -96.5% | -67.2% |
| 5 years | -97.4% | -51.7% |
| Since Jun 2018 | -99.9% | -54.5% |
Price by Year
Its best calendar year was 2025, when the price rose 98.4%, and its weakest was 2024, when it fell 93.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $2.38 | -67.4% |
| 2025 | $7.30 | +98.4% |
| 2024 | $3.68 | -93.8% |
| 2023 | $59.73 | +16.7% |
| 2022 | $51.19 | -22.7% |
| 2021 | $66.23 | -34.6% |
| 2020 | $101.30 | -71.3% |
| 2019 | $352.53 | -87.3% |
Trading Range
The price is 43.8% below its 50-day average of $2.83 and 56.5% below its 200-day average of $3.65.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.59 | |
| 52-week high | $12.42 | -87.2% |
| 52-week low | $1.33 | +19.5% |
| 50-day average | $2.83 | -43.8% |
| 200-day average | $3.65 | -56.5% |
Price Risk
Over 3 years, its largest fall from a peak was 98.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.53 |
| Largest fall, 1 year | -87.4% |
| Largest fall, 3 years | -98.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About QNTM
What is QNTM's 1-year price change?
Quantum BioPharma's price fell 78.4% over the past 12 months. With dividends included, the 12-month total return was -78.4%.
What is QNTM's 5-year price change?
Quantum BioPharma's month-end price fell 97.4% over the 5 years through Oct 2026, a compound annual decline of 51.7%. These figures leave out dividends.
What is QNTM's 52-week high and low?
Quantum BioPharma's 52-week high is $12.42 and its 52-week low is $1.33. Its latest price of $1.59 on Nov 17, 2026 is 87.2% below the high.
What is QNTM's beta?
Quantum BioPharma's 1-year beta against the S&P 500 is 0.53, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 87.4%.
Is the QNTM chart free?
Yes. Advanced Charting for QNTM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
QNTM pages: Overview, Charting, Earnings, Statistics, Competitors